Kaohsiung Medical University

Longyi Bio-medical Technology Ltd.

Yao-Hsien Wang

Mei-Ling Ho

Je-Ken Chang

Che-Hsin Lin

Rajalakshmanan Eswaramoorthy

Shun-Cheng Wu

Cherng-Chyi Tzeng

Yin-Chih Fu

Gwo-Jaw Wang

Hui-Ting Chen

Chung-Hwan Chen

The present invention provides a plasma device for skin repair, which includes a plasma head, a power supply, a gas supply source, and a control box. The plasma head includes an inner sleeve and an outer sleeve which are sleeved together. The inner sleeve has a first bottom portion having several first through holes. The outer sleeve has a second bottom portion having several second through holes. A gap is formed between the first bottom portion and the second bottom portion. The power supply is configured to provide 13.56 MHz to 54 MHz radio frequency power to generate a discharge in the gap. The gas supply source is configured to provide reaction gas into the gap, and plasma is formed by the reaction gas under the discharge. The control box is configured to control operating parameters of the plasma head, the power supply, and the gas supply source.

Plasma device for skin treatment

An automatic cell isolation and collection system for sorting out target cells from a sample includes a crush module, a centrifuge module, a transport module, and a control unit. The centrifuge module includes centrifuge tubes and a magnetic mechanism providing a magnetically attractive force to at least one of the centrifuge tubes. The control unit electrically communicates with the crush module, the centrifuge module, and the transport module, and controls operation of the crush module, transport of the sample via the transport module after the sample is crushed by the crush module, centrifugation of the centrifuge module, and operation of the magnetic mechanism for providing the magnetically attractive force.

Automatic cell isolation and collection system

A method for bone regeneration which comprises administering a short term release composition into a bone area of a subject in need thereof, wherein the composition comprises a poly(lactic-co-glycolic acid) cross-linked alendronate (PLGA-ALN), wherein the composition releases the alendronate into the bone area, wherein the bone tissue of the bone area is exposed in situ to a therapeutically effective amount of the alendronate over 9 days.

Method for bone formation by administering poly(lactic-co-glycolic acid) cross-linked alendronate

A method for locally controlled release of an effective amount of PTH(1-34) by a hyaluronic acid based hydrogel that can injected intra-articularly for the treatment of osteoarthritis is provided.

Method for controlled release of parathyroid hormone from cross-linked hyaluronic acid hydrogel

Growing community of inventors

Kaohsiung, Taiwan

Yao-Hsien Wang